36786 Federal Register / Vol. 87, No. 118 / Tuesday, June 21, 2022 / Proposed Rules 

dated July 12, 2021, if the retroactive actions 

identified in Bombardier Service Bulletin 

700–34–7521, Revision 03, dated July 27, 

2021; or Bombardier Service Bulletin 700– 

34–7521, Revision 04, dated December 6, 

2021; are done within 27 months after the 

effective date of this AD. 

(4) Credit is allowed for Bombardier 

Service Bulletin 700–34–7521, Revision 3, 

dated July 27, 2021. 

(5) Credit is allowed for Bombardier 

Service Bulletin 700–34–7523, dated April 1, 

2021, if the retroactive actions identified in 

Bombardier Service Bulletin 700–34–7523, 

Revision 01, dated December 8, 2021, are 

done within 27 months after the effective 

date of this AD. 

(j) Other FAA AD Provisions 

The following provisions also apply to this 

AD: 

(1) Alternative Methods of Compliance 

(AMOCs): The Manager, New York ACO 

Branch, FAA, has the authority to approve 

AMOCs for this AD, if requested using the 

procedures found in 14 CFR 39.19. In 

accordance with 14 CFR 39.19, send your 

request to your principal inspector or 

responsible Flight Standards Office, as 

appropriate. If sending information directly 

to the manager of the certification office, 

send it to ATTN: Program Manager, 

Continuing Operational Safety, FAA, New 

York ACO Branch, 1600 Stewart Avenue, 

Suite 410, Westbury, NY 11590; telephone 

516–228–7300. Before using any approved 

AMOC, notify your appropriate principal 

inspector, or lacking a principal inspector, 

the manager of the responsible Flight 

Standards Office. 

(2) Contacting the Manufacturer: For any 

requirement in this AD to obtain instructions 

from a manufacturer, the instructions must 

be accomplished using a method approved 

by the Manager, New York ACO Branch, 

FAA; or Transport Canada Civil Aviation 

(TCCA); or Bombardier, Inc.’s TCCA Design 

Approval Organization (DAO). If approved by 

the DAO, the approval must include the 

DAO-authorized signature. 

(k) Related Information 

(1) Refer to Mandatory Continuing 

Airworthiness Information (MCAI) TCCA AD 

CF–2021–36, dated November 1, 2021, for 

related information. This MCAI may be 

found in the AD docket on the internet at 

https://www.regulations.gov by searching for 

and locating Docket No. FAA–2022–0684. 

(2) For more information about this AD, 

contact Thomas Niczky, Aerospace Engineer, 

Airframe and Mechanical Systems Section, 

FAA, New York ACO Branch, 1600 Stewart 

Avenue, Suite 410, Westbury, NY 11590; 

telephone 516–228–7347; email 9-avs-nyacocos@faa.gov. 

(3) For service information identified in 

this AD, contact Bombardier Business 

Aircraft Customer Response Center, 400 CoˆteVertu Road West, Dorval, Que ́bec H4S 1Y9, 

Canada; telephone 1–514–855–2999; email 

ac.yul@aero.bombardier.com; internet 

https://www.bombardier.com. You may view 

this service information at the FAA, 

Airworthiness Products Section, Operational 

Safety Branch, 2200 South 216th St., Des 

Moines, WA. For information on the 

availability of this material at the FAA, call 

206–231–3195. 

Issued on June 13, 2022. 

Christina Underwood, 

Acting Director, Compliance & Airworthiness 

Division, Aircraft Certification Service. 

[FR Doc. 2022–13170 Filed 6–17–22; 8:45 am] 

BILLING CODE 4910–13–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

21 CFR Parts 1162 and 1166 

[Docket Nos. FDA–2021–N–1349 and FDA– 

2021–N–1309] 

RIN 0910–AI60 and 0910–AI28 

Establishment of Tobacco Product 

Standards for Menthol in Cigarettes 

and Characterizing Flavors in Cigars; 

Extension of Comment Period 

AGENCY: Food and Drug Administration, 

Department of Health and Human 

Services (HHS). 

ACTION: Proposed rules; extension of 

comment period. 

SUMMARY: The Food and Drug 

Administration (FDA, the Agency, or 

we) is extending the comment period for 

two proposed rules that appeared in the 

Federal Register of May 4, 2022, which 

are a tobacco product standard that 

would prohibit menthol as a 

characterizing flavor in cigarettes 

(‘‘Tobacco Product Standard for 

Menthol in Cigarettes’’; Docket No. 

FDA–2021–N–1349) and a tobacco 

product standard that would prohibit 

characterizing flavors (other than 

tobacco) in all cigars (‘‘Tobacco Product 

Standard for Characterizing Flavors in 

Cigars’’; Docket No. FDA–2021–N– 

1309). The Agency is taking this action 

in response to requests for an extension 

to allow interested persons additional 

time to submit comments. 

DATES: FDA is extending the comment 

period on the proposed rules published 

in the Federal Register on May 4, 2022 

(87 FR 26454 and 87 FR 26396). Submit 

either electronic or written comments 

by August 2, 2022. 

ADDRESSES: You may submit comments 

as follows. Please note that late, 

untimely filed comments will not be 

considered. The https://

www.regulations.gov electronic filing 

system will accept comments until 

11:59 p.m. Eastern Time at the end of 

August 2, 2022. Comments received by 

mail/hand delivery/courier (for written/ 

paper submissions) will be considered 

timely if they are postmarked or the 

delivery service acceptance receipt is on 

or before that date. 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to https://

www.regulations.gov will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be 

posted on https://www.regulations.gov. 

• If you want to submit a comment 

with confidential information that you 

do not wish to be made available to the 

public, submit the comment as a 

written/paper submission and in the 

manner detailed (see ‘‘Written/Paper 

Submissions’’ and ‘‘Instructions’’). 

Written/Paper Submissions 

Submit written/paper submissions as 

follows: 

• Mail/Hand Delivery/Courier (for 

written/paper submissions): Dockets 

Management Staff (HFA–305), Food and 

Drug Administration, 5630 Fishers 

Lane, Rm. 1061, Rockville, MD 20852. 

• For written/paper comments 

submitted to the Dockets Management 

Staff, FDA will post your comment, as 

well as any attachments, except for 

information submitted, marked and 

identified, as confidential, if submitted 

as detailed in ‘‘Instructions.’’ 

Instructions: All submissions received 

must include the Docket No. FDA– 

2021–N–1349 for ‘‘Tobacco Product 

Standard for Menthol in Cigarettes’’ 

and/or Docket No. FDA–2021–N–1309 

for ‘‘Tobacco Product Standard for 

Characterizing Flavors in Cigars.’’ 

Received comments, those filed in a 

timely manner (see ADDRESSES), will be 

placed in the docket and, except for 

those submitted as ‘‘Confidential 

Submissions,’’ publicly viewable at 

https://www.regulations.gov or at the 

Dockets Management Staff between 9 

a.m. and 4 p.m., Monday through 

Friday, 240–402–7500. 

• Confidential Submissions—To 

submit a comment with confidential 


jspears on DSK121TN23PROD with PROPOSALS1
Federal Register / Vol. 87, No. 118 / Tuesday, June 21, 2022 / Proposed Rules 36787 

information that you do not wish to be 

made publicly available, submit your 

comments only as a written/paper 

submission. You should submit two 

copies total. One copy will include the 

information you claim to be confidential 

with a heading or cover note that states 

‘‘THIS DOCUMENT CONTAINS 

CONFIDENTIAL INFORMATION.’’ The 

Agency will review this copy, including 

the claimed confidential information, in 

its consideration of comments. The 

second copy, which will have the 

claimed confidential information 

redacted/blacked out, will be available 

for public viewing and posted on 

https://www.regulations.gov. Submit 

both copies to the Dockets Management 

Staff. If you do not wish your name and 

contact information to be made publicly 

available, you can provide this 

information on the cover sheet and not 

in the body of your comments and you 

must identify this information as 

‘‘confidential.’’ Any information marked 

as ‘‘confidential’’ will not be disclosed 

except in accordance with 21 CFR 10.20 

and other applicable disclosure law. For 

more information about FDA’s posting 

of comments to public dockets, see 80 

FR 56469, September 18, 2015, or access 

the information at: https://

www.govinfo.gov/content/pkg/FR-2015- 

09-18/pdf/2015-23389.pdf. 

Docket: For access to the docket to 

read background documents or the 

electronic and written/paper comments 

received, go to https://

www.regulations.gov and insert the 

docket number, found in brackets in the 

heading of this document, into the 

‘‘Search’’ box and follow the prompts 

and/or go to the Dockets Management 

Staff, 5630 Fishers Lane, Rm. 1061, 

Rockville, MD 20852, 240–402–7500. 

FOR FURTHER INFORMATION CONTACT: Beth 

Buckler or Nate Mease, Center for 

Tobacco Products, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Silver Spring, MD 20993–0002, 

877–287–1373, CTPRegulations@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of May 4, 2022 (87 FR 

26454 and 87 FR 26396), FDA published 

two proposed rules: (1) a tobacco 

product standard that would prohibit 

menthol as a characterizing flavor in 

cigarettes (‘‘Tobacco Product Standard 

for Menthol in Cigarettes’’; Docket No. 

FDA–2021–N–1349) and (2) a tobacco 

product standard that would prohibit 

characterizing flavors (other than 

tobacco) in all cigars (‘‘Tobacco Product 

Standard for Characterizing Flavors in 

Cigars’’; Docket No. FDA–2021–N– 

1309). Both proposed rules published 

with a 60-day comment period. 

Comments on the proposed rules will 

inform FDA’s rulemakings to establish 

tobacco product standards for menthol 

in cigarettes and characterizing flavors 

in cigars. 

Interested persons were originally 

given until July 5, 2022, to comment on 

the proposed rules. We have received a 

number of requests for a 60-day 

extension of the comment period for 

both proposed rules, which conveyed 

concern that the current 60-day 

comment period does not allow 

sufficient time to develop a meaningful 

response to the proposed rules. Several 

organizations have requested that FDA 

close the comment period after 60 days, 

conveying that 60 days is enough time 

to receive meaningful responses and 

stressed a public health urgency with 

both product standards. 

FDA has considered the requests and 

is extending the comment period for the 

proposed rules by an additional 30 days, 

until August 2, 2022. We believe that a 

90-day comment period is appropriate 

as it allows adequate time for interested 

persons to fully consider the proposed 

rules, including specific requests for 

comments, and develop and submit 

comments without significantly 

lengthening the rulemaking 

proceedings. 

Dated: June 14, 2022. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2022–13209 Filed 6–17–22; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF JUSTICE 

28 CFR Part 0 

[BOP Docket No. 1179; AG Order No. 5439– 

2022] 

RIN 1120–AB79 

Home Confinement Under the 

Coronavirus Aid, Relief, and Economic 

Security (CARES) Act 

AGENCY: Office of the Attorney General, 

Department of Justice. 

ACTION: Proposed rule. 

SUMMARY: The Coronavirus Aid, Relief, 

and Economic Security Act (‘‘CARES 

Act’’) authorizes the Director of the 

Bureau of Prisons (‘‘Director’’), during 

the covered emergency period and upon 

a finding by the Attorney General that 

emergency conditions resulting from the 

Coronavirus Disease 2019 (‘‘COVID– 

19’’) pandemic materially affect the 

functioning of the Bureau of Prisons 

(‘‘Bureau’’ or ‘‘BOP’’), to lengthen the 

maximum amount of time for which a 

prisoner may be placed in home 

confinement. This proposed rule affirms 

that the Director has the authority to 

allow prisoners placed in home 

confinement under the CARES Act to 

remain in home confinement after the 

expiration of the covered emergency 

period. 

DATES: Comments are due on or before 

July 21, 2022. 

ADDRESSES: Please submit electronic 

comments through the regulations.gov 

website. In the alternative, written 

comments may be mailed to the Rules 

Unit, Office of General Counsel, Bureau 

of Prisons, 320 First Street NW, 

Washington, DC 20534. 

FOR FURTHER INFORMATION CONTACT: 

Crista Colvin, Office of General Counsel, 

Bureau of Prisons, phone (202) 353– 

4885. 

SUPPLEMENTARY INFORMATION: 

I. Posting of Public Comments 

Please note that all comments 

received are considered part of the 

public record and made available for 

public inspection online at 

www.regulations.gov. If you want to 

submit personal identifying information 

(such as your name, address, etc.) as 

part of your comment, but do not want 

it to be posted online, you must include 

the phrase ‘‘PERSONAL IDENTIFYING 

INFORMATION’’ in the first paragraph 

of your comment. You must also locate 

all the personal identifying information 

you do not want posted online in the 

first paragraph of your comment and 

identify what information you want 

redacted. 

If you want to submit confidential 

business information as part of your 

comment but do not want it to be posted 

online, you must include the phrase 

‘‘CONFIDENTIAL BUSINESS 

INFORMATION’’ in the first paragraph 

of your comment. You must also 

prominently identify the confidential 

business information to be redacted 

within the comment. If a comment has 

so much confidential business 

information that it cannot be effectively 

redacted, all or part of that comment 

may not be posted at 

www.regulations.gov. 

Personal identifying information 

identified and located as set forth above 

will be placed in the agency’s public 

docket file, but not posted online. 

Confidential business information 

identified and located as set forth above 

will not be placed in the public docket 

file, nor will it be posted online. If you 

want to inspect the agency’s public 

docket file in person by appointment, 

please see the FOR FURTHER INFORMATION

CONTACT paragraph. 


jspears on DSK121TN23PROD with PROPOSALS1